Showing results (991-1000 of 1,038) with videos related to

Sort By:
Pageof 104
International Journal of Radiation Oncology, Biology, Physics|August 30, 2017
Relapse Rates With Surgery Alone in Human Papillomavirus-Related Intermediate- and High-Risk Group Oropharynx Squamous Cell Cancer: A Multi-Institutional ReviewDavid M Routman, Ryan K Funk, Kanograt Tangsriwong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 23, 2018
Immunotherapy Targeting HPV16/18 Generates Potent Immune Responses in HPV-Associated Head and Neck CancerCharu Aggarwal, Roger B Cohen, Matthew P Morrow, et al.
British Journal of Pharmacology|August 8, 2026
Chemoproteomic discovery of a brain-penetrant, covalent NLRP3 inhibitor that binds a novel allosteric pocketDonald C Rogness, Evelyn P Sievert, Vincent F Vartabedian, et al.
Science Immunology|December 16, 2021
High-affinity, neutralizing antibodies to SARS-CoV-2 can be made without T follicular helper cellsJennifer S Chen, Ryan D Chow, Eric Song, et al.
The Journal of Clinical Investigation|October 1, 2024
Genomic and transcriptomic features of androgen receptor signaling inhibitor resistance in metastatic castration-resistant prostate cancerXiaolin Zhu, Tatyanah Farsh, Daniël Vis, et al.
Urologic Oncology|July 7, 2020
Down-regulation of ADRB2 expression is associated with small cell neuroendocrine prostate cancer and adverse clinical outcomes in castration-resistant prostate cancerDaniel H Kwon, Li Zhang, David A Quigley, et al.
Disaster Medicine and Public Health Preparedness|June 21, 2011
Mass casualty triage: an evaluation of the science and refinement of a national guidelineE Brooke Lerner, David C Cone, Eric S Weinstein, et al.
Oral Oncology|March 4, 2022
A benchmark for oncologic outcomes and model for lethal recurrence risk after transoral robotic resection of HPV-related oropharyngeal cancersRobert M Brody, David Shimunov, Roger B Cohen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 31, 2020
Copy Number Loss of 17q22 Is Associated with Enzalutamide Resistance and Poor Prognosis in Metastatic Castration-Resistant Prostate CancerXiangnan Guan, Duanchen Sun, Eric Lu, et al.
Genome Biology|April 16, 2026
Convergent evolution of complex structural variants drives therapy resistance in metastatic prostate cancerThaidy Moreno-Rodriguez, Meng Zhang, Arian Lundberg, et al.
Pageof 104